per month from March to July [Table 1]. Patient progression declined to 47.9% starting in January 2020 compared to 57.3% in 2018 and 59.4% in 2019 of the same month. Thereafter, progression to treatment dropped to an all-time low (February-March 2020 (32.0-33.0%)). Progression rate increased by late April 2020 (47.7%); and then surged in May 2020 (55.7%) superseding treatment progression rates between the same months during 2018 (47.4%) & 2019 (47.9%). By the end of August and throughout September 2020 progression to treatment restored itself to rates in 2018 & 2019 [Table 1].CONCLUSIONS: As compared to cohorts in 2018 and 2019, our study demonstrated a marked decline in progression to ART treatment that coincided with the onset of the COVID pandemic and when many regions of the country restricted all but urgent medical procedures. As COVID-related restrictions lifted, treatment progression rates sharply rebounded and then stabilized by September 2020. The recovery to treatment progression displays fertility care as essential to patients and reaffirms a strong desire to have children.IMPACT STATEMENT: The barriers related to the onset of the COVID pandemic were short-lived for patients who sought ART treatment. Even with COVID's introduction of new normal, patients can be reassured that they have the ability to access reproductive care and achieve parenthood.SUPPORT: None

No abstract

No abstract

No abstract

No abstract